AXIM Biotechnologies, Inc.
AXIM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $136 | -$234 | -$417 | -$534 |
| Dep. & Amort. | $108 | $108 | $110 | $106 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,002 | -$80 | $222 | $190 |
| Other Non-Cash | $84 | $73 | $6 | -$26 |
| Operating Cash Flow | -$674 | -$133 | -$78 | -$263 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $669 | $140 | $55 | $225 |
| Stock Issued | $0 | $0 | $23 | $33 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $669 | $140 | $78 | $258 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4 | $7 | -$0 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7 | $0 | $1 | $6 |
| End Cash | $3 | $7 | $0 | $1 |
| Free Cash Flow | -$674 | -$133 | -$78 | -$263 |